Author:
Cavelti-Weder Claudia,Timper Katharina,Seelig Eleonora,Keller Cornelia,Osranek Martin,Lässing Ute,Spohn Gunther,Maurer Patrik,Müller Philipp,Jennings Gary T,Willers Joerg,Saudan Philippe,Donath Marc Y,Bachmann Martin F
Subject
Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine
Reference23 articles.
1. Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases;Dinarello;Nat Rev Drug Discov,2012
2. Cryopyrin-associated periodic syndromes: diagnosis and management;Miyamae;Paediatr Drugs,2012
3. Interleukin-1-receptor antagonist in type 2 diabetes mellitus;Larsen;N Engl J Med,2007
4. Treatment with Anakinra improves disposition index but not insulin sensitivity in nondiabetic subjects with the metabolic syndrome: a randomized, double-blind, placebo-controlled study;van Asseldonk;J Clin Endocrinol Metab,2011
5. Effects of interleukin-1β inhibition with canakinumab on hemoglobin A1c, lipids, C-reactive protein, interleukin-6, and fibrinogen: a phase IIb randomized, placebo-controlled trial;Ridker;Circulation,2012
Cited by
57 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献